ISSN: 1309 - 3843 E-ISSN: 1307 - 7384
FİZİKSEL TIP VE REHABİLİTASYON
BİLİMLERİ DERGİSİ
www.jpmrs.com
Kayıtlı İndexler


ORIJINAL ARAŞTIRMA

Postmenopozal Osteoporozda Sistemik İmmün İnflamasyon İndeksinin Prognostik Rolünün Değerlendirilmesi
Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal Osteoporosis
Received Date : 20 May 2022
Accepted Date : 22 Jul 2022
Available Online : 12 Aug 2022
Doi: 10.31609/jpmrs.2022-91431 - Makale Dili: EN
J PMR Sci. 2022;25(3):369-76
ÖZET
Amaç: Bu çalışmanın amacı, postmenopozal osteoporozda sistemik immün inflamasyon indeksinin (SII) prognostik rolünün değerlendirilmesi ve SII, nötrofil-lenfosit oranı (NLO), platelet-lenfosit oranı (PLO), ortalama platelet hacmi (OPH), eritrosit sedimentasyon hızı (ESH), C-reaktif protein (CRP), femur ve lomber vertebra kemik mineral dansitometri (KMD) T skorlarının ve birbirleriyle ilişkilerinin incelenmesidir. Gereç ve Yöntemler: Bu retrospektif vaka-kontrol çalışmasına 139 hasta dâhil edildi. Lomber vertebra 1-4, femur boynu KMD T skorları, yaş, ESH, CRP, OPH değerleri kaydedildi. NLO, PLO ve SII değerleri hesaplandı. Lomber ve femoral T skoru ≥-1 olan hastalar kontrol grubunu (n=31); lomber veya femoral T skoru -1 ve -2,5 arasında olan hastalar osteopeni grubunu (n=38), ≤-2,5 olan hastalar osteoporoz grubunu (n=37), ≤-2,5 ve 1 ya da daha fazla frajilite kırığı olanlar şiddetli osteoporoz grubunu (n=33) oluşturdu. Bulgular: SII değeri osteoporoz grubunda osteopeni grubuna göre anlamlı olarak daha yüksekti (p=0,004). SII değerinin osteopenik hastalarda osteoporozu öngörmede tanısal değeri vardı (eğri altındaki alan: 0,686, %95 güven aralığı: 0,565-0,806, p<0,006); SII için kestirim değeri 458,46 olarak hesaplandı. ESH değeri şiddetli osteoporoz grubunda osteopeni ve kontrol gruplarına kıyasla anlamlı olarak daha yüksekti (p<0,001, p=0,0080). Gruplar arasında diğer değişkenler açısından anlamlı farklılık yoktu (p>0,05). Sonuç: SII değeri, postmenopozal osteopenik hastalarda osteoporoz gelişimini öngörmede kullanılabilecek prognostik bir prediktör olabilir.
ABSTRACT
Objective: The aim of this study is to evaluate the prognostic role of the systemic immune inflammation index (SII) in postmenopausal osteoporosis and to examine the SII, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), mean platelet volume (MPV), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), femur and lumbar bone mineral densitometry (BMD) T scores and their relationships with each other. Material and Methods: 139 patients were included in this retrospective case-control study. Lumbar vertebra 1-4 and femoral neck BMD T scores, ages, ESR, CRP, MPV values were recorded. NLR, PLR, and SII values were calculated. Patients with lumbar and femoral T scores ≥-1 were the control group (n=31); with lumbar or femoral T scores between -1 and -2.5 were the osteopenia group (n=38), ≤-2.5 were the osteoporosis group (n=37), ≤-2.5 and one or more fragility fractures were the severe osteoporosis group (n=33). Results: SII value was significantly higher in the osteoporosis group compared to the osteopenia group (p=0.004). SII value had a diagnostic value in predicting osteoporosis in patients with osteopenia (area under curve: 0.686, %95 confidence interval: 0.565-0.806, p<0.006); the cut-off value for the SII was calculated as 458.46. ESR value was significantly higher in the severe osteoporosis group compared to the osteopenia group and the control group (p<0.001, p=0.0080). There was no significant difference between the groups in terms of other variables (p>0.05). Conclusion: SII value can be a prognostic predictor that can be used to predict the development of osteoporosis in postmenopausal osteopenic patients.
REFERENCES
  1. Porter JL, Varacallo M. Osteoporosis. StatPearls [Internet]. Published online 2020:1-8. Available from: [Link] 
  2. Kanis JA, Cooper C, Rizzoli R, et al; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30:3-44. [Crossref]  [PubMed]  [PMC] 
  3. Rosen CJ. The Epidemiology and Pathogenesis of Osteoporosis. Endotext [Internet]. Published online June 21, 2020. Available from: [Link] 
  4. Nuti R, Brandi ML, Checchia G, et al. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med. 2019;14:85-102. [Crossref]  [PubMed]  [PMC] 
  5. Fang H, Zhang H, Wang Z, et al. Systemic immune-inflammation index acts as a novel diagnostic biomarker for postmenopausal osteoporosis and could predict the risk of osteoporotic fracture. J Clin Lab Anal. 2020;34:e23016. [Crossref]  [PubMed]  [PMC] 
  6. Lee SH, Ryu SY, Park J, et al. The relationship of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with bone mineral density in Korean postmenopausal women. Chonnam Med J. 2019;55:150-5. [Crossref]  [PubMed]  [PMC] 
  7. Kilic E, Rezvani A, Erek Toprak A ve ark. [Evaluation of neutrophil to lymphocyte and platelet to lymphocyte ratios in rheumatoid arthritis]. Dicle Med J. 2016;43:241-7.
  8. Önalan E, Gökalp Y. The relationship between bone mineral density and hematological parameters in the geriatric age group. Fam Pract Palliat Care. 2020;5:1-5. [Crossref] 
  9. Eroglu S, Karatas G. Platelet/lymphocyte ratio is an independent predictor for osteoporosis. Saudi Med J. 2019;40:360-6. [Crossref]  [PubMed]  [PMC] 
  10. Yildirim A, Bulut HT. [Association between bone mineral density and platelet indices in postmenopausal women]. Türk Osteoporoz Derg. 2016;22:92-6. [Crossref] 
  11. Huang C, Li S. Association of blood neutrophil lymphocyte ratio in the patients with postmenopausal osteoporosis. Pak J Med Sci. 2016;32:762-5. [Crossref]  [PubMed]  [PMC] 
  12. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212-22. [Crossref]  [PubMed] 
  13. Zhang Y, Chen B, Wang L, et al. Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: a meta-analysis. Medicine (Baltimore). 2019;98:e13788. [Crossref]  [PubMed]  [PMC] 
  14. Wang B, Huang Y, Lin T. Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore). 2020;99:e18571. [Crossref]  [PubMed]  [PMC] 
  15. Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Oncol. 2020;18:197. [Crossref]  [PubMed]  [PMC] 
  16. Zhong JH, Huang DH, Chen ZY. Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:75381-8. [Crossref]  [PubMed]  [PMC] 
  17. Huang Y, Gao Y, Wu Y, et al. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis. Cancer Cell Int. 20202;20:499. [Crossref]  [PubMed]  [PMC] 
  18. Usul E, Şan İ, Bekgöz B, et al. Role of hematological parameters in COVID-19 patients in the emergency room. Biomark Med. 2020;14:1207-15. [Crossref]  [PubMed]  [PMC] 
  19. Fois AG, Paliogiannis P, Scano V, et al. The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020;25:5725. [Crossref]  [PubMed]  [PMC] 
  20. Al-Daghri NM, Aziz I, Yakout S, et al. Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine (Baltimore). 2017;96(4):e5780. [Crossref]  [PubMed]  [PMC] 
  21. Schett G, Kiechl S, Weger S, et al High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006;166:2495-501. [Crossref]  [PubMed] 
  22. Cauley JA, Danielson ME, Boudreau RM, et al; Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007;22:1088-95. [Crossref]  [PubMed] 
  23. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group [‎meeting held in Rome from 22 to 25 June 1992]‎. Geneva: World Health Organization; 1994. Available from: [Link] 
  24. Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177:575-80. [Crossref]  [PubMed]  [PMC] 
  25. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195-202. [Crossref]  [PubMed] 
  26. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108-12. [Crossref]  [PubMed] 
  27. Adami G, Fassio A, Rossini M, et al. Osteoporosis in rheumatic diseases. Int J Mol Sci. 2019;20:5867. [Crossref]  [PubMed]  [PMC] 
  28. Öztürk ZA, Yesil Y, Kuyumcu ME, et al. Inverse relationship between neutrophil lymphocyte ratio (NLR) and bone mineral density (BMD) in elderly people. Arch Gerontol Geriatr. 2013;57:81-5. [Crossref]  [PubMed] 
  29. Satis S. New inflammatory marker associated with disease activity in rheumatoid arthritis: the systemic immune-inflammation index. Curr Health Sci J. 2021;47:553-7. [PubMed]  [PMC] 
  30. Kelesoglu Dincer AB, Sezer S. Systemic Immune Inflammation Index as a Reliable Disease Activity Marker in Psoriatic Arthritis. J Coll Physicians Surg Pak. 2022;32:773-8. [Crossref]  [PubMed] 
  31. Kim JW, Jung JY, Suh CH, et al. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease. Clin Rheumatol. 2021;40:661-8. [Crossref]  [PubMed] 
  32. Wu J, Yan L, Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal. 2021;35(9):e23964. [Crossref]  [PubMed]  [PMC] 
  33. Tanacan E, Dincer D, Erdogan FG, et al. A cutoff value for the Systemic Immune-Inflammation Index in determining activity of Behçet disease. Clin Exp Dermatol. 2021;46:286-91. [Crossref]  [PubMed] 
  34. Wang ZC, Jiang W, Chen X, et al. Systemic immune-inflammation index independently predicts poor survival of older adults with hip fracture: a prospective cohort study. BMC Geriatr. 2021;21:155. [Crossref]  [PubMed]  [PMC] 
  35. Du YN, Chen YJ, Zhang HY, et al. Inverse association between systemic immune-inflammation index and bone mineral density in postmenopausal women. Gynecol Endocrinol. 2021;37:650-4. [Crossref]  [PubMed]